Arbutus Biopharma Corp Interest Expense
Arbutus Biopharma Corp (ABUS) reported Interest Expense of $34.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-08
- Arbutus Biopharma Corp interest expense for the quarter ending 2024-06-30 was $34.00K, a 80.12% decline year-over-year.
- Arbutus Biopharma Corp interest expense for the quarter ending 2024-03-31 was $44.00K, a 77.78% decline year-over-year.
- Arbutus Biopharma Corp interest expense for the quarter ending 2023-12-31 was $44.00K, a 85.76% decline year-over-year.
- Arbutus Biopharma Corp interest expense for the quarter ending 2023-09-30 was $46.00K, a 89.28% decline year-over-year.
- Arbutus Biopharma Corp interest expense for fiscal 2023 was $459.00K, a 73.41% decline from fiscal 2022.
- Arbutus Biopharma Corp interest expense for fiscal 2022 was $1.73M, a 39.59% decline from fiscal 2021.
- Arbutus Biopharma Corp interest expense for fiscal 2021 was $2.86M, a 28.77% decline from fiscal 2020.
- Arbutus Biopharma Corp interest expense for fiscal 2020 was $4.01M, a 90.28% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $34.00K 10-Q · filed 2024-08-08 | $78.00K 10-Q · filed 2024-08-08 | $122.00K derived: sum of 3 quarters · filed 2024-08-08 | $168.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $44.00K 10-Q · filed 2024-05-02 | $88.00K derived: sum of 2 quarters · filed 2024-05-02 | $134.00K derived: sum of 3 quarters · filed 2024-05-02 | $305.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $90.00K derived: sum of 2 quarters · filed 2024-03-05 | $261.00K derived: sum of 3 quarters · filed 2024-08-08 | $459.00K 10-K · filed 2024-03-05 |
| 2023-09-30 | $46.00K 10-Q · filed 2023-11-07 | $217.00K derived: sum of 2 quarters · filed 2024-08-08 | $415.00K 10-Q · filed 2023-11-07 | $724.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $171.00K 10-Q · filed 2024-08-08 | $369.00K 10-Q · filed 2024-08-08 | $678.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.11M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $198.00K 10-Q · filed 2024-05-02 | $507.00K derived: sum of 2 quarters · filed 2024-05-02 | $936.00K derived: sum of 3 quarters · filed 2024-05-02 | $1.42M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $309.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $738.00K derived: sum of 2 quarters · filed 2024-03-05 | $1.22M derived: sum of 3 quarters · filed 2024-03-05 | $1.73M 10-K · filed 2024-03-05 |
| 2022-09-30 | $429.00K 10-Q · filed 2023-11-07 | $911.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.42M 10-Q · filed 2023-11-07 | $1.98M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $482.00K 10-Q · filed 2023-08-03 | $988.00K 10-Q · filed 2023-08-03 | $1.55M derived: sum of 3 quarters · filed 2023-08-03 | $2.31M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $506.00K 10-Q · filed 2023-05-04 | $1.07M derived: sum of 2 quarters · filed 2023-05-04 | $1.83M derived: sum of 3 quarters · filed 2023-05-04 | $2.59M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.32M derived: sum of 2 quarters · filed 2023-03-02 | $2.08M derived: sum of 3 quarters · filed 2023-03-02 | $2.86M 10-K · filed 2023-03-02 |
| 2021-09-30 | $762.00K 10-Q · filed 2022-11-09 | $1.52M derived: sum of 2 quarters · filed 2022-11-09 | $2.30M 10-Q · filed 2022-11-09 | $3.09M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $763.00K 10-Q · filed 2022-08-04 | $1.53M 10-Q · filed 2022-08-04 | $2.33M derived: sum of 3 quarters · filed 2022-08-04 | $3.41M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $772.00K 10-Q · filed 2022-05-05 | $1.57M derived: sum of 2 quarters · filed 2022-05-05 | $2.64M derived: sum of 3 quarters · filed 2022-05-05 | $3.74M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.87M derived: sum of 2 quarters · filed 2022-03-03 | $2.97M derived: sum of 3 quarters · filed 2022-03-03 | $4.01M 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.07M 10-Q · filed 2021-11-04 | $2.17M derived: sum of 2 quarters · filed 2021-11-04 | $3.21M 10-Q · filed 2021-11-04 | $4.21M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-05 | $2.14M 10-Q · filed 2021-08-05 | $3.13M derived: sum of 3 quarters · filed 2021-08-05 | $4.23M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.04M 10-Q · filed 2021-05-05 | $2.04M derived: sum of 2 quarters · filed 2021-05-05 | $3.13M derived: sum of 3 quarters · filed 2021-05-05 | $3.14M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $994.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $2.09M derived: sum of 2 quarters · filed 2021-03-04 | $2.10M derived: sum of 3 quarters · filed 2021-03-04 | $2.11M 10-K · filed 2021-03-04 |
| 2019-09-30 | $1.10M 10-Q · filed 2020-11-05 | $1.10M derived: sum of 2 quarters · filed 2020-11-05 | $1.11M 10-Q · filed 2020-11-05 | $1.24M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.00K 10-Q · filed 2020-08-07 | $14.00K 10-Q · filed 2020-08-07 | $136.00K derived: sum of 3 quarters · filed 2020-08-07 | $136.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $12.00K 10-Q · filed 2020-05-11 | $134.00K derived: sum of 2 quarters · filed 2020-05-11 | $134.00K derived: sum of 3 quarters · filed 2020-05-11 | $134.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $122.00K derived: sum of 2 quarters · filed 2020-03-05 | $122.00K derived: sum of 3 quarters · filed 2020-03-05 | $226.00K 10-K · filed 2020-03-05 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $104.00K 10-Q · filed 2019-11-06 | $179.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-05 | $104.00K 10-Q · filed 2019-08-05 | $179.00K derived: sum of 3 quarters · filed 2019-08-05 | $255.00K derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $104.00K 10-Q · filed 2019-05-06 | $179.00K derived: sum of 2 quarters · filed 2019-05-06 | $255.00K derived: sum of 3 quarters · filed 2019-05-06 | $323.00K derived: sum of 4 quarters · filed 2019-05-06 |
| 2017-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $151.00K derived: sum of 2 quarters · filed 2019-03-07 | $219.00K derived: sum of 3 quarters · filed 2019-03-07 | $261.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $76.00K 10-Q · filed 2018-11-07 | $144.00K derived: sum of 2 quarters · filed 2018-11-07 | $186.00K 10-Q · filed 2018-11-07 | $186.00K derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $68.00K 10-Q · filed 2018-08-03 | $110.00K 10-Q · filed 2018-08-03 | $110.00K derived: sum of 3 quarters · filed 2018-08-03 | $110.00K derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | $42.00K 10-Q · filed 2018-05-04 | $42.00K derived: sum of 2 quarters · filed 2018-05-04 | $42.00K derived: sum of 3 quarters · filed 2018-05-04 | $42.00K derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | $0.00 10-K · filed 2018-03-16 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-02 | $0.00 derived: sum of 2 quarters · filed 2017-11-02 | $0.00 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-03 | $0.00 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |